期刊文献+

人巨细胞病毒糖蛋白B抗原表位在大肠杆菌中的表达

Expression of human cytomegalovirus glycoprotein B epitope
原文传递
导出
摘要 目的:利用大肠杆菌表达人巨细胞病毒(HCMV)糖蛋白B抗原表位AD1和AD2,对表达产物进行纯化,通过ELISA方法检测表达产物与感染HCMV的人血清之间的特异结合反应,探讨其用于临床检测的可行性。方法:以HCMV病毒基因组为模板,PCR扩增AD1和AD2基因,构建重组表达载体pET32-NusA-AD1和pET32-NusA-AD2,在大肠杆菌BL21(DE3)pLysS中利用IPTG诱导表达,通过Ni柱亲和纯化获得NusA-AD1和NusA-AD2,ELISA方法检测NusA-AD1和NusA-AD2与感染HCMV的人血清之间的特异性结合反应。结果:可溶性表达并纯化得到融合抗原NusA-AD1和NusA-AD2。在8份已确定为HCMV IgG阳性人血清标本中,融合抗原NusA-AD1能够与5份血清发生反应,融合抗原NusA-AD2能够与6份血清反应。结论:NusA-AD1和NusA-AD2能够部分检测HCMV感染的人血清。 Objective:To clone and express the epitope AD1 and AD2 of HCMV glycoprotein B(gB) in Escherichia coli, to purify the expression product and to detect sera from HCMV positive patients by ELISA assay for further clinical study, nethods:AD1 and AD2 genes were cloned by PCR using HCMV genome DNA as template and the recombinant expression vectors pET32-NusA-AD1 and pET32-NusA-AD2 were constructed. E. coli BL21 ( DE3 ) pLysS bearing the plasmids was induced with IPTG for protein production. The proteins NusA-AD1 and NusA-AD2 were purified by Ni^2+ affinity chromatography and used to detect HCMV positive human sera by ELISA method. Results: The recombinant antigens Nu- sA-AD1 and NusA-AD2 were expressed solubly. Of eight HCMV-IgG positive serum samples, five were found positive by NusA-AD1, and six were positive by NusA-AD2. Conclusion: Most HCMV positive human sera could be detected by recombinant antigens NusA-AD1 and NusA-AD2.
出处 《军事医学科学院院刊》 CSCD 北大核心 2007年第5期432-435,共4页 Bulletin of the Academy of Military Medical Sciences
基金 国家自然科学基金资助项目(30471556)
关键词 人巨细胞病毒 表位 克隆 检测 HCMV epitopes expression detection
  • 相关文献

参考文献10

  • 1Schleiss M. Progress in cytomegalovirus vaccine development [J]. Herpes,2005,12(3):66-75.
  • 2Gema G, Lilleri D. Monitoring transplant patients for human cytomegalovirus:diagnostic update[J]. Herpes, 2006,13( 1 ) :4 - 11.
  • 3Varnum SM, Streblow DN, Monroe ME, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome[J]. J Viral,2004,78(20) :10960 - 10966.
  • 4Shimamura M, Mach M, Britt WJ. Human cytomegalovirus infection elicits a glycoprotein M ( gM )/gN-specific virus-neutralizing antibody response[J]. J Virol, 2006,80(9) :4591 -4600.
  • 5Shanley JD, Wu CA. Intranasal immunization with a replicationdeficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity [ J ]. Vaccine, 2005,23:996 - 1003.
  • 6Bennekov T, Spector D, Langhoff E. Induction of immunity against human cytomegalovirus [ J ]. Mt Sinai J Med, 2004,71 (2) :86 -93.
  • 7许丽锋,张中洋,李秀玲,何薇薇.人巨细胞病毒gB基因真核表达载体的构建与鉴定[J].中国生物制品学杂志,2004,17(5):284-286. 被引量:3
  • 8萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎孟枫译.分子克隆实验指南[M] 第2版[M].北京:科学出版社,1992..
  • 9Gicklhom D, Eickmann M, Meyer G, et al. Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-indueed eeU-call fusion [ J ]. J Gen Virol, 2003, 84 ( Pt 7) ,1859 - 1862.
  • 10Kniess N, Mach M, Fay J,et al. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus [ J ]. J Virol, 1991,65( 1 ) :138-146.

二级参考文献3

  • 1Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis.Bioessays, 1995,17: 899-903.
  • 2Myers JD, Fluomoy N, Thomas ED. Nonbanterial pneumonia after allogenic marrow transplantation. A review of ten year's experience. Rey Infect Dis, 1982,4:1119-1132.
  • 3Jacobson MA,French M.Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.AIDS, 1998,12: S157-163.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部